"The extracts showed potential potent anti-inflammatory properties that could be beneficial in chronic inflammatory disease treatment."
"This is another great milestone for the research team, the company and the psychedelic industry as the findings are very remarkable. The anti-inflammatory effects are groundbreaking and the potential treatments it may offer to medicine are extraordinary. The research team led by Sanah M. Nkadimeng is making monumental progress in bringing concrete psychedelics research to the forefront of medicine. Paper #4 is ready for submission and we are very excited to share the findings in the near future," said Wuhan General Group CEO Jeff Robinson.
News 
Market Data 
Discover 
AI
